Company profile: Ethos Health Communications
1.1 - Company Overview
Company description
- Provider of medical and marketing communications services, offering medical affairs to analyze complex data and landscapes; KOL data solutions to identify, map, and track thought leader influence; training, learning and development across the product life cycle; pharma marketing for commercialization, launch planning, and multichannel execution; digital opinion leader mapping in healthcare; and scientific communications.
Products and services
- Scientific Communications: Generates evidence-based strategies and communications to differentiate products for medical and marketing communications supporting brand goals (evidence-based)
- Pharma Marketing: Develops commercialization strategies, launch planning, and multichannel marketing execution to help brands achieve their goals in healthcare marketing (multichannel)
- Medical Affairs: Analyzes complex data and evaluates landscapes to establish and communicate scientific foundations supporting brand medical communications (scientific)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ethos Health Communications
Apex Innovative Sciences
HQ: United States
Website
- Description: Provider of independent clinical trial site operations focused on central nervous system indications and other therapeutic areas, including neurology, psychiatry, and addiction, delivering high scientific and clinical quality for client partners and participants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apex Innovative Sciences company profile →
Rhenovia
HQ: France
Website
- Description: Provider of applications of biosimulation rooted in neuroscience and nervous system modeling, from a French biotechnology company founded in 2007 by managers from large pharmaceutical companies and world experts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rhenovia company profile →
Zenith Technologies
HQ: Ireland
Website
- Description: Provider of global full lifecycle automation, manufacturing, and operational support solutions for the life science industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zenith Technologies company profile →
BioMedion
HQ: Germany
Website
- Description: Provider of compliance management software and services for the highly regulated life science industry, medicines agencies, and national competent authorities. Offers GxP quality, compliance, and archiving solutions, including neuronOS, IMAGE+, WATCH+, regulatory operations services, raw data archiving, and subject-matter expertise, computer system validation, and training management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioMedion company profile →
Labcorp Drug Development
HQ: United States
Website
- Description: Provider of global contract research and drug development services, delivering early- and late-stage support including drug discovery studies, preclinical and clinical pharmacology, clinical trial execution with patient recruitment and data analysis, biomarker services, oncology research (cell line assays, tumor models), biopharma laboratory services with antibody-drug conjugate capabilities, and cell and gene therapy development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcorp Drug Development company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ethos Health Communications
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ethos Health Communications
2.2 - Growth funds investing in similar companies to Ethos Health Communications
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ethos Health Communications
4.2 - Public trading comparable groups for Ethos Health Communications
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →